Immunogenicity of Idursulfase and Clinical Outcomes in Very Young Patients (16 Months to 7.5 Years) With Mucopolysaccharidosis II (Hunter Syndrome)
Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/s13023-015-0265-2
Full Text
Open PDFAbstract
Available in full text
Date
April 24, 2015
Authors
Publisher
Springer Science and Business Media LLC